Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M A Alvarez-Soria"'
Autor:
Raquel Largo, Olga Sánchez-Pernaute, M A Alvarez-Soria, Gabriel Herrero-Beaumont, Jesús Egido, Emilio Calvo, J. Santillana, M Hernández
Publikováno v:
Annals of the Rheumatic Diseases. 65:998-1005
Objective: To compare the effect of celecoxib with that of a classic non-steroidal anti-inflammatory drug (NSAID) on synovial inflammation and on the synovial expression of proinflammatory genes in patients with knee osteoarthritis (OA). Methods: 30
Autor:
Emilio Calvo, Gabriel Herrero-Beaumont, Jesús Egido, M A Alvarez-Soria, Olga Sánchez-Pernaute, Raquel Largo
Publikováno v:
Annals of the Rheumatic Diseases. 62:1135-1138
Intracavitary fibrin clots may initiate pannus formation and the immunopathology of RA. Two critical steps, probably host dependent, may determine the development of RA: an altered regulation of extravascular haemostasis or an aberrant reactivity of
Autor:
I Díez-Ortego, M A Alvarez-Soria, Gabriel Herrero-Beaumont, Emilio Calvo, Jesús Egido, Raquel Largo, Olga Sánchez-Pernaute
Publikováno v:
Osteoarthritis and Cartilage. 11(4):290-298
Objective Glucosamine sulfate (GS) is a commonly used drug for the treatment of osteoarthritis. The mechanism of the action of this drug does, however, remain to be elucidated. In human osteoarthritic chondrocytes (HOC) stimulated with a proinflammat
Autor:
M J, Alvarez Soria, A, Hernández González, S, Carrasco García De León, M A, Del Real Francia, J M, Flores Barragán, M J, Gallardo Alcáñiz, M A, Gudín Rodríguez-Magariños, R, Ibáñez Alonso, J, Vaamonde Gamo
Publikováno v:
Neurologia (Barcelona, Spain). 27(9)
The need for safe health care, in which the care and treatment of the patient does not cause any injuries in addition to those already arising from their baseline disease, has led to the present study. Our objective has been to determine the frequenc
Autor:
Juan Moreno-Rubio, Gabriel Herrero-Beaumont, Lidia Tardio, M. Angeles Alvarez-Soria, Raquel Largo
Publikováno v:
Arthritis and rheumatism. 62(2)
Objective Although the osteoprotegerin (OPG)/RANK/RANKL system is the main modulator of bone remodeling, it remains unclear whether it is regulated in cartilage during osteoarthritis (OA). The aim of this study was to examine whether nonsteroidal ant
Autor:
M A Alvarez-Soria, Gabriel Herrero-Beaumont, María A. Contreras-Blasco, Raquel Largo, Jorge A. Roman-Blas, Santos Castañeda
Publikováno v:
European journal of pharmacology. 623(1-3)
Oxidative stress may play a relevant role in synovial inflammation and subsequently on cartilage damage during osteoarthritis development. We have assessed how the antioxidant N-acetylcysteine (NAC) affects the expression of different proinflammatory
Publikováno v:
Rheumatology (Oxford, England). 47(5)
Objectives. Synoviocytes play a crucial role in the inflammatory response leading to structural damage in OA. Our aim was to assess the effects of diacerein and NSAIDs on cellular responses of synoviocytes associated with inflammation and structural
Publikováno v:
Expert opinion on pharmacotherapy. 8(2)
Glucosamine is a natural amino sugar and a normal constituent of glycosaminoglycans in the cartilage matrix and synovial fluid of joints. Crystalline glucosamine sulfate salt has been approved as a medicinal product for the treatment of osteoarthriti
Autor:
M. Angeles Alvarez-Soria, Gabriel Herrero-Beaumont, Emilio Calvo, Raquel Largo, Jesús Egido, Olga Sánchez-Pernaute
Publikováno v:
Rheumatology international. 27(10)
Prostaglandin E2 (PGE2) exerts its actions through the binding of the high affinity EP receptors. We wanted to evaluate the regulation of EP1 and EP4, and the expression of cyclooxygenase (COX)-2, main enzyme responsible for PGE2 synthesis in inflamm
Autor:
Olga Sánchez-Pernaute, Gabriel Herrero-Beaumont, M E Marcos, Raquel Largo, S R de Córdoba, Emilio Calvo, M A Alvarez-Soria, Jorge Esparza-Gordillo
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
7 páginas, 6 figuras -- PAGS nros. 1279-1285
Background: C4b-binding protein (C4BP) is a plasma oligomeric glycoprotein that participates in the regulation of complement and haemostasis. Complement-regulatory activity depends on the C4BPα-poly
Background: C4b-binding protein (C4BP) is a plasma oligomeric glycoprotein that participates in the regulation of complement and haemostasis. Complement-regulatory activity depends on the C4BPα-poly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e9ce85cd41cd1c194e8e696506e8e22
https://europepmc.org/articles/PMC1798309/
https://europepmc.org/articles/PMC1798309/